The Healthcare Technology Report is pleased to announce The Top 25 Digital Health Executives of 2025. This year, Hinge Health’s IPO, led by CEO Daniel Perez, marked a defining moment in digital health, putting musculoskeletal care in the spotlight with a $2.6 billion valuation. Omada Health, guided by CEO Sean Duffy, followed with its own public debut, bringing virtual-first chronic disease management to the public markets. Consolidation accelerated as Co-Founder Demetri Karagas steered Thirty Madison into a $500 million acquisition by Remedy Meds, forming a scaled platform spanning men’s, women’s, and metabolic health.
Evidence and validation have been equally pivotal. April Koh’s Spring Health published a peer-reviewed JAMA study demonstrating a 1.9x return on employer behavioral health investments, giving rare third-party proof of financial value in mental healthcare. And at system scale, Farzad Mostashari’s Aledade achieved more than $1 billion in Medicare savings by improving outcomes for millions of patients in independent primary care practices.
Beyond these landmark achievements, the executives recognized this year are advancing the frontiers of healthcare through new applications of AI, large-scale partnerships, and patient-centered models of care.
This year’s awardees were selected through a methodical evaluation process that considered the scope of their business achievements, the innovations they and their teams have delivered, and the influence of their leadership on the healthcare industry. Please join us in recognizing The Top 25 Digital Health Executives of 2025.
Company: Doximity
Title: Co-Founder & CEO
Jeff Tangney is the Co-Founder and Chief Executive Officer of Doximity, a leading digital platform for U.S. medical professionals, offering tools for physician networking, clinical workflow, and telehealth. He began his career in finance with Goldman Sachs and ZS Associates before entering health technology in the late 1990s. He then co-founded Epocrates, a mobile drug reference app that became a widely used clinical tool, and as chief operating officer helped grow the company into a market leader before his departure in 2009.
Tangney went on to co-found Doximity in 2010 to connect physicians through a secure digital network that has since expanded to include telehealth, messaging, and workflow tools. The company went public in 2021 with a $9.4 billion valuation and reported revenue of $570 million in FY2025, a 20% year-over-year increase. Under his leadership in 2025, Doximity acquired Pathway Medical for $63 million to add clinical decision support capabilities and launched Doximity Scribe, an AI assistant designed to ease physicians’ documentation burden. Tangney earned his bachelor’s degree in economics and math from the University of Wisconsin-Madison and his MBA from Stanford University.
Company: Hinge Health
Title: Co-Founder & CEO
Daniel Perez is the Co-Founder and Chief Executive Officer of Hinge Health, a digital musculoskeletal clinic he launched in 2014 after experiencing the shortcomings of traditional rehabilitation firsthand. The company combines wearable sensors with motion-tracking artificial intelligence and behavioral support to deliver virtual physical therapy programs, and today works with thousands of employers and every major national health plan in the United States.
Perez guided Hinge Health through its initial public offering in May 2025, when it was valued at $2.6 billion following years of rapid expansion. Under his leadership, the company achieved a 77% gross margin in 2024 and scaled its offerings across Fortune 500 employers, supported by multiple fundraising rounds including a $400 million Series E in 2021.
Before co-founding Hinge Health, Perez was the Founder and CEO of Oxbridge Biotech Roundtable, a platform connecting academic and industry innovators in the life sciences. He also co-founded and led Marblar, a venture-backed health care product development company. Perez earned a bachelor’s degree in biology from Westminster University and a PhD in biochemistry from the University of Oxford.
Company: Lyra Health
Title: Chief Executive Officer
Jennifer Schulz became the Chief Executive Officer of Lyra Health in January 2025, assuming control over one of the biggest providers of mental health services in the U.S. Lyra offers coaching, therapy, and medication management to over 20 million members, with its customer base of 300+ employers including big names like Starbucks and Meta.
Under her leadership, Lyra introduced Lyra Empower in April 2025, an AI-powered platform that delivers insights and matching tools for HR leaders, and in July acquired Bend Health to expand into neurodiverse and pediatric mental health care.
Before joining Lyra, Schulz worked at Experian for more than a decade. There, she led the company’s $4.5 billion North American business and helped expand Experian Health to cover 60% of U.S. hospitals. She holds a bachelor’s degree in advertising and public relations from the University of Wisconsin-Madison and an MBA from the University of Michigan.
Company: Scene Health
Title: Co-Founder & CEO
Sebastian Seiguer is the Co-Founder and Chief Executive Officer of Scene Health, a company that uses video technology and behavioral coaching to improve medication adherence. Launched from Johns Hopkins in 2014, the platform utilizes “directly observed therapy” in a digital format to make adherence support scalable for health systems and payers.
Seiguer has guided the company through key milestones, including recognition from the Centers for Disease Control and Prevention in 2023 for its video-based monitoring as equivalent to in-person observation. In 2025, he oversaw the expansion of Panorama, Scene Health’s core care model, which has shown real-world impact such as reducing emergency department visits for people with type 2 diabetes by 26%.
Earlier in his career, Seiguer co-founded and grew San Francisco Coffee Company in Germany into a chain of 25 locations before transitioning into healthcare. He later worked with Johns Hopkins Technology Ventures as part of its analyst program, focusing on technology licensing and business development. He holds a bachelor’s degree in English from Columbia University, an MBA in healthcare and finance from The Johns Hopkins University, and a JD from Columbia Law School.
Company: Included Health
Title: President
As President of Included Health, Robin Glass leads the growth and business excellence organization, which includes general management, business operations, corporate communications and marketing, sales and client success, and client insights and analytics. She is responsible for ensuring that the company’s products deliver value to its clients. With over 20 years of experience, Robin has a proven track record of building and scaling growth organizations for innovative healthcare companies.
Prior to Included Health, Robin was the chief customer officer at Evolent Health, a publicly-traded value-based care company. Robin holds a bachelor’s degree in public policy from Duke University and an MBA and master’s degree in public administration fromHarvard University.
Company: Carbon Health
Title: Chief Executive Officer
Kerem Ozkay is the Chief Executive Officer of Carbon Health, a health technology company that combines urgent, primary, and virtual care into a single patient experience. He was appointed CEO in August 2024 after serving as chief operating officer, where he restructured operations and drove margin improvements to support the company’s growth.
In 2025, Ozkay directed Carbon’s expansion of PrEP and PEP services across all clinics, the launch of a redesigned mobile app to improve patient navigation, and a workplace-health partnership with the City of Corona, California.
Earlier in his career, Ozkay spent more than a decade at Z Gallerie in senior marketing and e-commerce roles. He also led marketing at missingSTEP, a finance and investing app company, and co-founded Composite3 Developments, where he managed marketing and web development strategy for B2C and B2B clients.
Company: Ro
Title: Co-Founder & CEO
Zachariah Reitano is the Co-Founder and Chief Executive Officer of Ro, a digital health company he launched in 2017 after personal health challenges and inspiration from his physician father highlighted barriers to care. Originally focused on men’s health under the name Roman, the company has since expanded into telehealth, diagnostics, pharmacy, and at-home care.
Under Reitano’s leadership, Ro has scaled rapidly, raising more than $1 billion across seven funding rounds and acquiring Modern Fertility and Kit in 2022 to broaden into women’s health and diagnostics. By 2024, the company was among the first digital health providers to integrate GLP-1 obesity drugs through a partnership with Eli Lilly. Today, Ro is one of the largest vertically integrated digital health platforms, serving millions of patients nationwide.
Earlier in his career, Reitano co-founded Shout, a Y Combinator-backed marketplace platform, and worked as an entrepreneur in residence at Prehype. He earned a bachelor’s degree in economics and creative writing from Columbia University.
Company: Komodo Health
Title: Co-Founder & CEO
Arif Nathoo is the Co-Founder and Chief Executive Officer of Komodo Health, a healthcare intelligence company launched in 2014. Komodo’s Healthcare Map captures the de-identified journeys of more than 330 million patients. In August 2025, under Nathoo’s leadership, the company introduced Marmot, a healthcare-native AI engine designed to accelerate drug development and care delivery by transforming complex analytics into evidence-based insights in minutes.
Nathoo has spent more than 15 years in healthcare and life sciences leadership roles. Before founding Komodo, he was a leader in McKinsey’s healthcare practice, where he co-led the firm’s medical affairs group and developed analytic tools to improve engagement between industry and providers.
Earlier in his career, he conducted research in instructional technologies and medical devices. Nathoo graduated with bachelor’s degree in neurobiology as well as a master’s degree in molecular and cellular biology from Harvard University, earned an MD from Harvard Medical School, and an MPA in health policy from the Harvard Kennedy School.
Company: Aledade
Title: Co-Founder & CEO
Farzad Mostashari, MD, is the Co-Founder and Chief Executive Officer of Aledade, the nation’s largest network of independent primary care practices. Aledade reported that its accountable care organizations saved Medicare more than $1 billion in 2024 by improving quality of care for over 1 million patients, preventing nearly 96,000 hospitalizations and 167,000 emergency department visits. In February 2025, the company added more than 500 new practices to its network, bringing its reach to 2,400 organizations serving nearly 3 million patients across the country.
Mostashari has spent his career at the intersection of healthcare policy and technology. He previously served as the national coordinator for health IT at the Department of Health and Human Services and as founder of the NYC Primary Care Information Project. In addition to leading Aledade, he chairs the board of Resolve to Save Lives, a global health organization, and co-chairs the Health Evolution Summit. Mostashari earned his MD from the Yale University School of Medicine and a master’s degree in population health from the Harvard T.H. Chan School of Public Health.
Company: Hello Heart
Title: Co-Founder & CEO
Maayan Cohen is the Co-Founder and Chief Executive Officer of Hello Heart, a digital platform dedicated to preventive heart health. Founded in 2013, the company offers an app paired with a connected monitor to help people track and manage their heart health, with peer-reviewed studies showing meaningful improvements in blood pressure, cholesterol, and weight among high-risk users.
Hello Heart is trusted by more than 130 Fortune 500 and government employers, national health plans, and labor organizations. In 2025, Cohen oversaw the launch of the Hello Heart Smart Pill Box, designed to improve adherence to heart medications through app integration, personalized reminders, and real-time tracking.
Before founding Hello Heart, Cohen led the retail and consumer goods practice at TASC Consulting & Capital in Tel Aviv and held earlier roles as an associate and business analyst at the firm. She also serves as an advisor to Empathy. Cohen earned both her MBA in entrepreneurship and innovation and her bachelor’s degree in biotechnology from Tel Aviv University.
Company: Headway
Title: Founder & CEO
Andrew Adams is the Founder and Chief Executive Officer of Headway, a mental health platform that went live in 2019 with the goal of improving access to in-network therapy. The company connects patients to clinicians, with the network surpassing 1 million patients in 2025.
Through its work with 34,000 providers and more than 40 payer partners, Headway now facilitates over 600,000 therapy sessions every month and it hit a $2.3 billion valuation in July 2024 after a $100 million Series D round. That same year, Adams also led the company to expand to serve people with Medicare Advantage and Medicaid insurance coverage.
Adams founded Headway after struggling to find affordable therapy himself, positioning the company to reduce barriers for patients, providers, and payers alike. He previously worked in product and investment roles at Spring, SoftBank Capital, and Amazon, and holds both a bachelor’s degree in English and a master’s degree in engineering from Stanford University.
Company: Viz.ai
Title: Co-Founder & CEO
Chris Mansi is Co-Founder and Chief Executive Officer of Viz.ai, a clinical AI company that is focused on improving stroke diagnoses and treatment. He trained as a neurosurgeon before earning an MBA at Stanford, where he co-founded Viz.ai in 2016. He guided the company to a major milestone in 2018, when it became the first platform of its kind to earn FDA clearance for an AI triage algorithm in stroke care.
Since then, Mansi has expanded Viz.ai into a suite of more than a dozen FDA-cleared tools across various neurological and cardiovascular conditions. As of 2025, the company’s platform supports over 1,700 hospitals and 60,000 providers in the U.S. and Europe, and it has formed partnerships with leading global pharmaceutical companies to extend its reach into cardiology, oncology, and beyond.
Earlier in his career, Mansi co-founded Edusurg and KC Surgical Training, ventures focused on advancing surgical education, and published research in cognitive science and neurosurgery. He received his bachelor of medicine and bachelor of surgery from University College London and a bachelor’s degree in cognitive science from the University of Cambridge.
Company: Pearl Health
Title: Co-Founder & CEO
Michael Kopko is the Co-Founder and Chief Executive Officer of Pearl Health, a physician enablement and risk management company that partners with thousands of primary care providers across 44 states. In 2025, he led Pearl through key milestones, including achieving HITRUST r2 Certification for its application and establishing a preferred partnership with DeepScribe to bring ambient AI documentation to more than 3,500 clinicians.
Kopko co-founded Pearl in 2020 after serving as VP at Oscar Health, where he managed the company’s largest business unit, a $2.5 billion P&L, and built its network contracting and business development functions. He previously worked at Bridgewater Associates in research and client service, reporting directly to CEO Ray Dalio as Head of Research Analytics. Kopko earned his bachelor’s degree in economics from Harvard University and an MBA from Columbia Business School.
Company: Zus Health
Title: Founder & CEO
Jonathan Bush is the Founder and Chief Executive Officer of Zus Health, a company building a shared health data platform to give clinicians a complete, real-time view of their patients’ care. In 2025, Zus launched a referral-tracking tool—described as a “Domino’s pizza tracker” for healthcare—at a Maine medical group, part of its effort to close communication gaps between providers. The company now works with more than 60 customers and has raised $74 million from investors including Andreessen Horowitz and Maverick Ventures.
Bush founded Zus in 2020 after two decades leading Athenahealth, which he co-founded in 1997 and grew into one of the country’s leading electronic health record providers before taking it public in 2007. He later served as executive chairman of Firefly Health, helping to shape its virtual-first primary care model.
Earlier in his career, Bush was a consultant with Booz Allen Hamilton, advising managed care and retail banking organizations on corporate strategy. He holds a bachelor’s degree in social studies from Wesleyan University and an MBA from Harvard Business School.
Company: EvidenceCare
Title: Co-Founder & Chief Medical Officer
Brian Fengler, MD, is the Co-Founder and Chief Medical Officer of EvidenceCare, a Nashville-based clinical decision support company. In 2025, he helped lead the launch of The BetterCare Platform™, which unified EvidenceCare’s physician-centered solutions and expanded the company’s investment in artificial intelligence, alongside the rebrand of its newly acquired Agathos product to CareInsights™. Earlier in the year, EvidenceCare’s acquisition of Agathos added new capabilities for reducing unwarranted clinical variation through data-driven insights and peer-comparison tools.
Fengler founded EvidenceCare in 2014 while practicing as an emergency medicine physician, where he experienced firsthand the difficulty clinicians faced in quickly accessing evidence-based content at the bedside. Before founding EvidenceCare, he practiced at St. Thomas Health System in Nashville, served as a founding physician and managing director of Physicians Urgent Care, and taught as an assistant professor of emergency medicine for the University of Tennessee/St. Thomas residency program.
Fengler earned his medical degree from Upstate Medical University and completed his residency at the University of Virginia Health System. He holds a bachelor’s degree in biology from the University at Albany.
Company: Recuro Health
Title: Chairman & CEO
Phil Fasano is the Chairman and Chief Executive Officer of Recuro Health, a digital health company providing a virtual-first platform for primary care, behavioral health, urgent care, and supplemental benefits including pharmacy, care management, and genetic testing. He became CEO in 2023 after serving on the company’s board and is leading Recuro through its next phase of growth in personalized, proactive virtual care.
Fasano previously served as EVP and chief information officer at Kaiser Permanente, where he oversaw the development and scaling of the organization’s first telehealth offering, extending access to more than 14 million members and contributing to revenue growth from $47 billion to $70 billion.
Earlier in his career, he held senior leadership roles at American International Group, Capital One, JPMorgan Chase, and Deutsche Bank. Fasano earned a bachelor’s degree in computer science from the New York Institute of Technology and an MBA in finance from Long Island University.
Company: HealthJoy
Title: Co-Founder & CEO
Justin Holland is the Co-Founder and Chief Executive Officer of HealthJoy, a healthcare navigation company that simplifies employee benefits through a mobile-first platform. In 2025, he led HealthJoy into a strategic partnership with CareValidate to improve access and affordability for GLP-1 medications, offering members savings of up to 50% while helping employers contain pharmacy costs.
HealthJoy also expanded its pharmacy savings tools by integrating with a leading coupon service, further reducing costs for members. Today, the company serves more than 1,800 employer clients and over 1 million members and dependents nationwide.
Holland co-founded HealthJoy in 2014 to address the complexity of healthcare and benefits navigation, drawing on earlier experience in technology and product development. Before launching HealthJoy, he co-founded OpenInstall, acquired by AVG Technologies in 2012, and held leadership roles at FreeCause, a Rakuten company, where he managed international product integrations and major client partnerships.
He began his career building loyalty and advertising technology solutions and holds a bachelor’s degree in mechanical engineering and management from the Massachusetts Institute of Technology.
Company: Luma Health
Title: Co-Founder & CEO
Adnan Iqbal is the Co-Founder and Chief Executive Officer of Luma Health, a patient engagement company whose AI-native Patient Success Platform™ is used by more than 750 healthcare organizations and 500,000 providers.
Under his leadership, Luma launched Spark in 2024, a generative AI framework embedded across the platform to reduce staff workload and improve patient access. By 2025, the company reported major adoption milestones, including international expansion into Canada and the United Kingdom and support for over 100 million patients.
Iqbal co-founded Luma Health in 2015 to simplify the process of connecting patients with providers and reduce bottlenecks in access to care. The platform has since enabled more than $3.2 billion in healthcare revenue while continuing to expand its capabilities in EHR integration, AI-powered workflows, and patient engagement.
Earlier in his career, Iqbal spent five years at Genentech in roles spanning finance, R&D strategy, and commercial planning, where he guided product positioning and portfolio investment decisions across oncology, immunology, and neuroscience. He holds a bachelor’s degree in environmental biology from the University of California, Berkeley, a master of philosophy in bioscience from the University of Cambridge, and an MBA from Stanford Graduate School of Business.
Company: Spring Health
Title: Co-Founder & CEO
April Koh is the Co-Founder and Chief Executive Officer of Spring Health, a comprehensive mental health platform serving more than 20 million people worldwide. In 2025, the company published a peer-reviewed study in JAMA Network Open demonstrating a 1.9x return on investment for employer-sponsored behavioral health benefits, validating its performance-based approach to mental healthcare.
Koh co-founded Spring Health in 2016 while at Yale University, where she earned a bachelor’s degree in sociology and computer science. Under her leadership, the company has grown into one of the highest-valued female-founded startups in the world, reaching a $3.3 billion valuation in 2024. She has been recognized as the youngest woman to lead a unicorn company and serves on the Board of Trustees for McLean Hospital.
Company: Virta Health
Title: Chief People Officer
Lucia Guillory is the Chief People Officer of Virta Health, a digital health company working to reverse type 2 diabetes and obesity through a personalized nutrition program supported by clinical expertise and technology. Since joining in 2019, Guillory has led the company’s people strategy during a period of tenfold headcount growth, shaping Virta into a fully distributed, remote-first workforce recognized by Inc. as one of the Best Places to Work.
Previously, Guillory was head of people at Patreon, where she built the HR and talent systems from the ground up, guided a fivefold workforce expansion through acquisitions and international growth, and co-created a new approach to company values and diversity standards. Earlier in her career, she held senior HR roles at Yahoo, including chief of staff to the head of HR and leader of global employee engagement, supporting teams across EMEA, APAC, and the Americas. Guillory earned a PhD in organizational behavior from the Stanford Graduate School of Business and a bachelor’s degree in psychology from the University of Houston.
Company: Thirty Madison
Title: Co-Founder
Demetri Karagas is the Co-Founder of Thirty Madison, a virtual specialty care company serving patients with chronic conditions across the United States. In September 2025, Karagas led the company through a pivotal transaction: a definitive agreement for Thirty Madison to be acquired by Remedy Meds in an all-stock deal valued at more than $500 million. At the time of the agreement, Thirty Madison was profitable with more than $225 million in projected revenue, joining Remedy’s portfolio to create one of the nation’s largest digital health platforms spanning men’s, women’s, and metabolic health.
Since co-founding Thirty Madison in 2017, Karagas has built a portfolio of brands including Keeps for men’s health, Nurx for women’s health, and Cove for migraine care, collectively serving millions of patients and supported by a nationwide network of clinicians. His earlier ventures include founding a startup later acquired by Homejoy, where he served as entrepreneur in residence, and holding operational roles at Google. Karagas earned his bachelor’s degree in finance and history from New York University.
Company: Omada Health
Title: Co-Founder & CEO
Sean Duffy is the Co-Founder and Chief Executive Officer of Omada Health, a virtual-first healthcare provider focused on chronic disease management. In 2025, he led the company through its initial public offering, marking one of the most notable digital health IPOs of the year. Omada has also published important findings this year showing that members maintained weight loss after discontinuing GLP-1 medications. Today, the company partners with more than 2,000 enterprise customers and has enrolled nearly one million members nationwide.
Duffy co-founded Omada in 2011 with the goal of making between-visit care clinically meaningful through digital programs. During his tenure, Omada became the first virtual provider to secure NCQA and URAC accreditation in its core care areas, and the company’s clinical results have been published in nearly 30 peer-reviewed journals.
He previously worked at Medgadget as a healthcare innovation writer and editor and founded Excel Everest, a widely used interactive Microsoft Excel training tool. Earlier in his career, he also trained in healthcare innovation at IDEO. Duffy earned his bachelor’s degree from Harvard University and attended Harvard Medical School before leaving to build Omada.
Company: Ada Health
Title: Co-Founder & Chief Medical Officer
Claire Novorol is the Co-Founder and Chief Medical Officer of Ada Health, a global health company known for its AI-powered symptom assessment platform. Under her leadership, Ada has grown to more than 13 million users worldwide and has facilitated over 32 million health assessments. The company’s technology, validated in more than 25 peer-reviewed studies and certified as a Class IIa medical device in Europe, is used by health systems, insurers, and life sciences organizations to guide patients and support clinical decision-making.
Novorol trained as a pediatrician in London before specializing in clinical genetics. She earned degrees in pathology and medicine from the University of Bristol, followed by a PhD in neuroscience from the University of Cambridge. Beyond Ada, she founded the Doctorpreneurs network for medical entrepreneurs and serves as a board member, mentor, and advisor to multiple health technology startups.
Company: Rula Health
Title: Co-Founder & CEO
Josh Bruno is the Co-Founder and Chief Executive Officer of Rula Health, a national behavioral healthcare provider group dedicated to improving access to high-quality mental health care. Under his leadership, Rula has built one of the country’s largest behavioral health networks, with more than 15,000 licensed providers across all 50 states, delivering millions of therapy sessions and making care accessible to over 120 million people through in-network insurance coverage.
Rula’s technology-enabled platform matches patients with best-fit therapists or psychiatric practitioners, verifies insurance in real time, and offers next-day availability—reducing barriers that often prevent people from starting and sustaining care. In 2025, Rula partnered with Sohar Health to integrate AI-powered insurance verification into its intake process, eliminating bottlenecks and enabling patients to match with the right providers more quickly.
Bruno co-founded Rula in 2018 after years of experience as both an entrepreneur and investor. He previously founded Hometeam, a home health company acquired by Google’s Homejoy, and worked as a venture investor at Bain Capital Ventures. Earlier in his career, he held roles at Bain & Company and Yahoo. He earned a bachelor’s degree in electrical and computer engineering from The University of Texas at Austin.
Company: Cadence
Title: Founder & CEO
Chris Altchek is the Founder and Chief Executive Officer of Cadence, a remote care delivery company that partners with health systems to bring proactive, personalized care into patients’ homes. Under his leadership, Cadence has scaled to support more than 50,000 patients across 18 leading health systems, with clinical results including a 52% reduction in total cost of care for heart failure patients and high patient satisfaction scores. In 2025, the company launched its AI-powered Proactive Care Engine, extending its chronic disease programs into advanced primary care management for Medicare patients nationwide.
Before founding Cadence in 2020, Altchek co-founded and led Mic, a digital media company later acquired by Bustle Digital Group, where he went on to serve as EVP of corporate development and oversaw acquisitions of major titles including W Magazine and Nylon. He began his career at Goldman Sachs, focusing on public-private partnerships for infrastructure projects. Altchek earned his bachelor’s degree in social studies from Harvard University.
link